Clinical Trials
21 trialsNCT07070973 2026-05-11
HEMOPEC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Recruiting
NCT02876107 2026-04-15
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07365618 2026-01-26
LymFit
Faculdade de Motricidade Humana
Phase NA Not yet recruiting
NCT02411656 2026-01-23
Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04606030 2025-03-11
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
Fibralign Corporation
Phase NA Recruiting
NCT05104528 2024-01-17
Non-Invasive Cardiometry and Ultrasound Guided Inferior Vena Cava Collapsibility Index in Assessing Fluid Responsiveness
National Cancer Institute, Egypt
Phase NA Completed
NCT06101498 2023-11-27
Peroperative Fluid Management in Major Gynecological Cancer Surgeries
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Phase NA Completed
NCT03580213 2023-09-22
Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?
Haukeland University Hospital
Phase NA Completed
NCT02734979 2022-10-27
Biobridge
Stanford University
Phase NA Completed
NCT04907812 2021-06-01
THAW
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4 Unknown
NCT01805453 2020-05-08
ASTER
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT03477565 2018-03-26
BREASTAPE
IRCCS San Raffaele
Phase NA Unknown
NCT02627976 2018-01-30
Breast Edema Compression Vest
UMC Utrecht
Phase NA Completed
NCT02158832 2017-08-30
Acupuncture for Lymphedema Secondary to Breast Cancer Treatment
McMaster University
Phase NA Withdrawn
NCT02707835 2016-03-17
Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping
National Taiwan University Hospital
Phase NA Unknown
NCT00088166 2014-08-13
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Celtic Pharma Development Services
Phase 3 Completed
NCT01369121 2013-07-30
Tolerability Study of Xerecept® in Pediatric Patients
Celtic Pharma Development Services
Phase 1/2 Terminated
NCT01508260 2013-04-05
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00226655 2012-08-31
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Celtic Pharma Development Services
Phase 3 Completed
NCT00226668 2008-01-03
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Celtic Pharma Development Services
Phase 3 Withdrawn
NCT00441662 2007-03-01
Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema
Wills Eye
Phase NA Completed